SB 218 establishes a private right of action, allowing minors, their legal guardians, or estates to file civil lawsuits against healthcare professionals and physicians. These lawsuits can be brought for injuries caused by specific medical interventions, including certain surgeries, hormone therapies, and puberty blockers, when provided to minors to treat gender dysphoria. Liability may arise if the injury is proximately caused by a deviation from the applicable medical standard of care. The bill sets a statute of limitations for these actions and clarifies that it does not apply to treatments for medically verifiable disorders of sex development or complications from prior medical treatments.
HB 601 establishes an online portal by May 1, 2026, to assist Medicaid applicants and enrollees. This portal allows designated "community assisters" to help individuals apply for Medicaid coverage and submit required documents. Key functions include enabling assisters to review application status, view department notices, report eligibility changes, and update contact information for their clients. The portal also allows, but does not require, assisters to submit initial applications or redeterminations and upload verification documents. This aims to streamline the application process for individuals seeking Medicaid assistance through community organizations.
HB 687 revises the age range for expanded Medicaid participants who are required to engage in community engagement activities. Previously, participants aged 19 to 55 were subject to this requirement. This bill extends that upper age limit, now requiring individuals from 19 to 62 years old to participate. Affected participants must complete 80 hours per month in activities such as employment, education, work training, or community service, unless they qualify for an exemption. This change directly impacts expanded Medicaid recipients between the ages of 56 and 62.
HB 600 authorizes public and nonpublic schools to maintain a supply of "stock albuterol," a quick-relief asthma medication, for emergency use. This medication can be administered by a school nurse or other authorized school personnel to any individual, student or non-student, experiencing respiratory distress on school grounds or at school-related activities. Schools choosing to keep stock albuterol must develop a protocol for staff training, medication maintenance, and post-administration follow-up, including determining when to make a 9-1-1 emergency call. The bill requires a prescription for the stock albuterol, with the school designated as the patient.
HB 607, known as the "Hearing Aid Coverage Act," proposes to expand health insurance coverage for hearing loss. The bill revises current law that mandates coverage only for children, extending this requirement to include individuals of all ages. It achieves this by amending sections 2-18-704 and 33-22-128 of the Montana Code Annotated, which govern mandatory provisions in insurance contracts. This change would require state insurance plans to cover treatment for hearing loss for both children and adults.
Senate Bill 495 eliminates the Tobacco Prevention Advisory Board. The bill repeals the specific section of law that established this board. It also amends existing statute to remove the board from the list of entities funded by state special revenue accounts, which are primarily used for tobacco disease prevention programs and the Children's Health Insurance Program. The direct effect is the dissolution of the advisory board, which previously provided guidance for these programs.
SB 279 enacts the Dietitian Licensure Compact, which allows licensed dietitians and nutritionists to practice in multiple participating states through a "compact privilege" without needing to obtain a separate license in each state. This bill aims to improve public access to dietetics services and reduce administrative burdens for practitioners and state licensing authorities. It establishes uniform requirements for licensure portability, including criminal background checks, and supports military members and their spouses. The compact also enhances cooperation among states in regulating the profession and protecting public health and safety.
HB 41 adds gabapentin to Montana's Schedule V list of controlled substances under the "depressants" category. This change directly affects medical providers who prescribe gabapentin (used for nerve pain, seizures, and other conditions), pharmacists who dispense it, and patients using the medication. The bill amends Montana Code § 50-32-232 to explicitly include gabapentin - identified by its chemical name "1-(aminomethyl)cyclohexaneacetic acid" - in Schedule V depressants alongside drugs like pregabalin. This policy update standardizes gabapentin's regulatory classification without altering its medical use or prescribing rules.
